Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug ...

In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...

Hundreds of people have reported problems with their pancreas after taking GLP-1 agonists, including ten deaths.

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...

Signs of advanced chronic pancreatitis include weight loss, a loss of appetite, jaundice, other symptoms associated with ...

Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of ...

The once-monthly drug is still under study but could provide added convenience and another option for patients.

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...

For the first time, 40-year-old Manmeet Bindra feels motivated to exercise and has set up a home gym, cleaned up her diet and ...

However, if you're planning to ask your GP to prescribe it, are you actually eligible and do you meet the very specific ...

An injectable weight-loss treatment is now available through primary care across the UK - and general practices across ...